Latest Autoimmune Disease Therapeutics News

Page 1 of 1

Noxopharm and Tezcat Biosciences Unlock New Potential for Sofra™ Drug Delivery

Noxopharm’s Sofra™ technology shows promising results in collaboration with US biotech Tezcat Biosciences, advancing targeted drug delivery for cancer and inflammatory diseases.

Ada Torres

5 Aug 2025

Noxopharm Advances HERACLES Trial with Safe Low-Dose SOF-SKN Completion

Noxopharm Limited has successfully completed the first low-dose cohort in its HERACLES clinical trial for SOF-SKN™, clearing the way for higher dose testing in autoimmune disease treatment.

Ada Torres

28 July 2025